Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-17

FDA Approved: BIMATOPROST — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approved the original application for Bimatoprost by Lifestar Pharma LLC, granting approval for a generic ophthalmic solution intended to reduce intraocular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

ORIG AP for BIMATOPROST (BIMATOPROST)